awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q56897833-198AB9D8-5377-48CC-86B3-140290C413A2
Q56897833-198AB9D8-5377-48CC-86B3-140290C413A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q56897833-198AB9D8-5377-48CC-86B3-140290C413A2
Preclinical efficacy and immunological safety of FR104, an antagonist anti-CD28 monovalent Fab' antibody
P2860
Q56897833-198AB9D8-5377-48CC-86B3-140290C413A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q56897833-198AB9D8-5377-48CC-86B3-140290C413A2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
066cb4ca53d908fb5479d443aa42b1c0c1d8e2c6
P2860
Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.